Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea

NCT05283954 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

SARS-CoV2 Infection
COVID-19

Interventions

DRUG: Combination regimen: Fluoxetine, Prednisolone, Ivermectin
DRUG: Combination regimen: Albendazole, Vitamin C

Sponsor

Oriol Mitja

Collaborators

[object Object]
[object Object]